Director/PDMR Shareholding

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Smith & Nephew plc ordinary shares of USD 0.20 each

Identification code

ISIN: GB0009223206

Nature of the transaction

Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2025 interim dividend payment on 7 November 2025.

Date of Transaction

2025 - 11 - 07

Place of Transaction

London Stock Exchange (XLON)

Name

(Position)

Director / PDMR

Price (£)

Volume

Aggregated information

Scott Schaffner

(President, Sports Medicine)

PDMR

12.4048

746.79305

N/A Single Transaction

Deepak Nath

(Chief Executive Officer)

Director

12.4048

2624.43651

N/A Single Transaction

Rohit Kashyap (President, Advanced Wound Management and Global Commercial Operations)

PDMR

12.4048

427.09066

N/A Single Transaction

Craig Gaffin

(President, Orthopaedics)

PDMR

12.4048

197.25944

N/A Single Transaction

Mizanu Kebede

(Chief Quality & Regulatory Affairs Officer)

PDMR

12.4048

4.1729

N/A Single Transaction

Paul Connolly

(President, Global Operations)

PDMR

12.4048

394.41542

N/A Single Transaction